VANCOUVER, British Columbia, Sept. 19, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced that Bob Butchofsky, President and Chief Executive Officer, will be presenting at the UBS Global Life Sciences Conference on Tuesday, September 20, 2011, at 8:30 a.m. Eastern Time at the Grand Hyatt Hotel in New York.
The live audio webcast of QLT's presentation can be accessed through the Company's web site at www.qltinc.com. A replay of the presentation, with slides, will be available through October 21, 2011.
About QLT
QLT is an ocular-focused company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases, developing drugs to be delivered in our proprietary punctal plug delivery system, as well as U.S. marketing of the commercial product Visudyne® (which we co-developed with Novartis) for the treatment of wet age-related macular degeneration. QLT's head office is based in Vancouver, Canada and the Company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT). For more information about the Company's products and developments, please visit our web site at www.qltinc.com.
Visudyne® is a registered trademark of Novartis AG.
The QLT Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6933